ask="0.171"
ask_size="5400"
average_daily_volume="4166510"
bid="0.160"
bid_size="10500"
book_value="0.104"
change="-0.005"
change_from_200_day_moving_average="-0.062"
change_from_50_day_moving_average="-0.023"
change_from_52_week_high="-0.477"
change_From_52_week_low="0.008"
change_in_percent="-2.976%"
close="0.163"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.678"
ebitda="-16.86M"
eps_estimate_current_year="-0.620"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="0.170"
ex_dividend_date="N/A"
float_shares="125385000"
high="0.168"
high_52_weeks="0.640"
last_trade_date="3/9/2017"
last_trade_price="0.163"
last_trade_size="660"
last_trade_time="3:59pm"
low="0.162"
low_52_weeks="0.155"
market_capitalization="21.40M"
moving_average_200_day="0.225"
moving_average_50_day="0.186"
name="Immune Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="3.000"
open="0.165"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-27.602%"
percent_change_from_50_day_moving_average="-12.500%"
percent_change_from_52_week_high="-74.531%"
percent_change_from_52_week_low="+5.093%"
previous_close="0.168"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.615"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="131291000"
short_ratio="2.980"
stock_exchange="NCM"
symbol="IMNP"
volume="2053338"
weeks_range_52="0.155 - 0.640"
